Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-107746
Filing Date
2021-08-19
Accepted
2021-08-19 16:16:49
Documents
4
Effectiveness Date
2021-08-19

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2125431d1_s8.htm S-8 77633
2 EXHIBIT 5.1 tm2125431d1_ex5-1.htm EX-5.1 8955
3 EXHIBIT 23.2 tm2125431d1_ex23-2.htm EX-23.2 2033
4 GRAPHIC tm2125431d1_ex5-1img001.jpg GRAPHIC 4754
  Complete submission text file 0001104659-21-107746.txt   96464
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258937 | Film No.: 211190272
SIC: 2834 Pharmaceutical Preparations